Newman DK (2010) Surgical management of the late complications of proliferative diabetic retinopathy. Eye 24:441–449. https://doi.org/10.1038/eye.2009.325
Article CAS PubMed Google Scholar
Everett LA, Paulus YM (2021) Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 21:35. https://doi.org/10.1007/s11892-021-01403-6
Article PubMed PubMed Central Google Scholar
Sun JK, Glassman AR, Beaulieu WT, Stockdale CR, Bressler NM, Flaxel C, Gross JG, Shami M, Jampol LM (2019) Rationale and application of the protocol s anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy. Ophthalmology 126:87–95. https://doi.org/10.1016/j.ophtha.2018.08.001
Wang YR, Sun X, Xie YM, Du A, Chen M, Lai SS, Wei XH, Ji LL, Wang CH (2024) Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: association with the NF-κB signaling pathway. J Ethnopharmacol 319:117135. https://doi.org/10.1016/j.jep.2023.117135
Article CAS PubMed Google Scholar
Zhou P, Xie WJ, Meng XB, Zhai YD, Dong X, Zhang XL, Sun GB, Sun XB (2019) Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells 8:213. https://doi.org/10.3390/cells8030213
Article CAS PubMed PubMed Central Google Scholar
Fan CL, Qiao Y, Tang MK (2017) Notoginsenoside R1 attenuates high glucose-induced endothelial damage in rat retinal capillary endothelial cells by modulating the intracellular redox state. Drug Des Dev Ther 11:3343–3354. https://doi.org/10.2147/dddt.S149700
Dong CX, Liu P, Wang HZ, Dong M, Li GX, Li YB (2019) Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats. Acta Cir Bras 34:e201900201. https://doi.org/10.1590/s0102-8650201900201
Article PubMed PubMed Central Google Scholar
Xue LP, Hu M, Li JJ, Li YD, Zhu Q, Zhou GL, Zhang XF, Zhou Y, Zhang JY, Ding P (2022) Ginsenoside Rg1 inhibits high glucose-induced proliferation, migration, and angiogenesis in retinal endothelial cells by regulating the lncRNA SNHG7/miR-2116-5p/SIRT3 axis. J Oncol 2022:6184631. https://doi.org/10.1155/2022/6184631
Article CAS PubMed PubMed Central Google Scholar
Zhang SN, Ju ZC, Guan HD, Yu L, Wang ZT, Zhao YQ (2019) Dose-dependent exposure profile and metabolic characterization of notoginsenoside R(1) in rat plasma by ultra-fast liquid chromatography-electrospray ionization-tandem mass spectrometry. Biomed Chromatogr 33:e4670. https://doi.org/10.1002/bmc.4670
Article CAS PubMed Google Scholar
Li XQ, Li L, Liu XF, Liu JH (2017) Metabolism of saponins of Panax notoginseng by human intestinal microflora in vitro. Pharm Biotechnol 24:218–223. https://doi.org/10.19526/j.cnki.1005-8915.20170306
Guo ZQ, Gao LC, Chen F, Ma YB, Han L (2018) Research progress on preparation methods and pharmacological activity of 20 (S) -protopanaxadiol. World Latest Med Inform 18:26–27. https://doi.org/10.19613/j.cnki.1671-3141.2018.62.011
Chen XL, Shi DZ, Si RH, Liu JP, Li PY (2021) Research progress on the biological activity and mechanism of Protopanaxatriol. J Liaoning Univ Tradit Chin Med 23:209–214. https://doi.org/10.13194/j.issn.1673-842x.2021.02.047
Xie JQ, Li YH, Liang YL, Kui HQ, Wang C, Huang JM (2023) Integration of non-targeted metabolomics with network pharmacology deciphers the anxiolytic mechanisms of Platycladi Semen extracts in CUMS mice. J Ethnopharmacol 315:116571. https://doi.org/10.1016/j.jep.2023.116571
Article CAS PubMed Google Scholar
Zhang J, Xie JQ, Liang YL, Li YH, Zhang YC, Wang C, Huang JM (2022) Anxiolytic effects, metabolism and plasma pharmacokinetics of 3, 6’-disinapoylsucrose. Biomed Pharmacother 149:112913. https://doi.org/10.1016/j.biopha.2022.112913
Article CAS PubMed Google Scholar
Lei Y, Xie JQ, Xie ZS, Zhao X, Wang CJ, Huang JM (2025) Comparative drug-drug interactions of Berberine and Astragaloside IV in normal and type 2 diabetes mellitus rats based on UPLC-QqQ-MS/MS. Acta Mater Med 4:51–69. https://doi.org/10.15212/AMM-2024-0078
Lee Y, Yang J (2021) Development of a zebrafish screening model for diabetic retinopathy induced by hyperglycemia: reproducibility verification in animal model. Biomed Pharmacother 135:111201. https://doi.org/10.1016/j.biopha.2020.111201
Article CAS PubMed Google Scholar
Jung SH, Kim YS, Lee YR, Kim JS (2016) High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy. Br J Pharmacol 173(1):15–26. https://doi.org/10.1111/bph.13279
Article CAS PubMed Google Scholar
Wang C, Wang Y, Ma SR, Zuo ZY, Wu YB, Kong WJ, Wang AP, Jiang JD (2019) Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci Rep 9:13415. https://doi.org/10.1038/s41598-019-50103-5
Article CAS PubMed PubMed Central Google Scholar
Wang C, Cheng YY, Zhang YH, Jin HT, Zuo ZY, Wang AP, Huang JM, Jiang JD, Kong WJ (2021) Berberine and its main metabolite berberrubine inhibit platelet activation through suppressing the class i PI3Kβ/Rasa3/Rap1 pathway. Front Pharmacol 12:734603. https://doi.org/10.3389/fphar.2021.734603
Article CAS PubMed PubMed Central Google Scholar
Yuan ZS, Tian Y, Zhang C, Wang MS, Xie JQ, Wang C, Huang JM (2023) Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1868:159382. https://doi.org/10.1016/j.bbalip.2023.159382
Article CAS PubMed Google Scholar
Wang C, Yuan ZS, Xie JQ, Lei Y, Li YH, Huang JM, Kong WJ, Jiang JD (2023) Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice. Eur J Pharmacol 938:175436. https://doi.org/10.1016/j.ejphar.2022.175436
Article CAS PubMed Google Scholar
Yu X, Wu H, Zhou L, Wang G, Sun X, Miao J, Ben M, Shi R, Wan S, Li S, Wang X, Zhou X, Zhao Y (2025) Ameliorative effect and potential mechanism of hyperoside on diabetic retinopathy. Front Endocrinol (Lausanne) 16:1556310. https://doi.org/10.3389/fendo.2025.1556310
Article PubMed PubMed Central Google Scholar
Zhou L, Zhang T, Lu B, Yu Z, Mei X, Abulizi P, Ji L (2016) Lonicerae japonicae flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. J Ethnopharmacol 189:117–125. https://doi.org/10.1016/j.jep.2016.05.039
Article CAS PubMed Google Scholar
Sun K, Chen Y, Zheng S, Wan W, Hu K (2024) Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways. Phytomedicine 129:155596. https://doi.org/10.1016/j.phymed.2024.155596
Article CAS PubMed Google Scholar
Deng XQ, Zhao JQ, Qu LL, Duan ZG, Fu RZ, Zhu CH, Fan DD (2020) Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. Biochem Pharmacol 178:114038. https://doi.org/10.1016/j.bcp.2020.114038
Article CAS PubMed Google Scholar
Li YH, Liang YL, Xie JQ, Wang C, Huang JM (2024) Research progress on biotransformation of saponins from traditional Chinese medicine. Chin Tradit Herb Drugs 55:989–1003. https://doi.org/10.7501/j.issn.0253-2670.2024.03.029
Deng JJ, Liu Y, Duan ZG, Zhu CH, Hui JF, Yu M, Ma P, Ma XX, Fan DD, Yang HX (2017) Protopanaxadiol and Protopanaxatriol-type saponins ameliorate glucose and lipid metabolism in type 2 diabetes mellitus in High-Fat Diet/Streptozocin-Induced mice. Front Pharmacol 8:506. https://doi.org/10.3389/fphar.2017.00506
Comments (0)